Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07404189 · ClinicalTrials.gov registry record · NA

Augmenting Primary Care-Based Obesity Management With the Nutu™ Digital Health Platform

A NA study, sponsored by University of Alabama at Birmingham.

Not yet
Registry status
NA
Development phase
300
Enrollment target

NCT07404189: Clinical Trial NA study, sponsored by University of Alabama at Birmingham.

NCT07404189 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07404189, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.

NOT YET RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target

Study Summary

This study evaluates the acceptability and clinical effectiveness of integrating the Nutu™ digital health platform into a comprehensive primary care-based behavioral obesity treatment program using a Zelen randomized controlled trial design.

Primary Outcome

Difference in body weight change between groups

Interventions

  • BEHAVIORAL FLOW Program
  • BEHAVIORAL Nutu™ Offer

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2026-08
Est. Completion 2028-06
Phase NA
University of Alabama at Birmingham

1,160 total trials

What is known before NCT07404189 opens enrollment

NCT07404189 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 2 interventions - of which FLOW Program is the first listed.

NCT07404189 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07404189 about?

NCT07404189 is a clinical study titled "Augmenting Primary Care-Based Obesity Management With the Nutu™ Digital Health Platform". This study evaluates the acceptability and clinical effectiveness of integrating the Nutu™ digital health platform into a comprehensive primary care-based behavioral obesity treatment program using a Zelen randomized controlled trial design.

What is the current status of trial NCT07404189?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-08. Estimated completion is 2028-06.

What interventions are being tested in trial NCT07404189?

The interventions under investigation include: FLOW Program (BEHAVIORAL), Nutu™ Offer (BEHAVIORAL).

Who is sponsoring clinical trial NCT07404189?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07404189's enrollment target sits among peer trials

300 330th of 2000 higher than 1,630 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07404189, the US trial registry maintained by the National Library of Medicine. NCT07404189 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.